Description du projet DEENESFRITPL L’intelligence artificielle pour diagnostiquer les cancers Alors que le nombre de cas de cancer dans le monde augmente, il est urgent d’établir un système de diagnostic rapide et précis. Les approches existantes demandent beaucoup de temps et dépendent fortement des connaissances et de l’expérience de pathologistes qualifiés. Pour passer outre ces limites, le projet AIPACA, financé par l’UE, entend développer un logiciel basé sur l’intelligence artificielle capable d’analyser des lames de biopsie en quelques secondes, d’identifier les régions tumorales et de quantifier les biomarqueurs des tumeurs. Grâce à des fonctions d’apprentissage approfondi, le logiciel devrait diminuer considérablement le temps de traitement des biopsies et faciliter les diagnostics. En outre, il réduira au minimum les variations en matière de diagnostic, offrant un outil clinique robuste et fiable. Afficher les objectifs du projet Masquer les objectifs du projet Objectif MindPeak is an innovative start-up that builds diagnostic support tools for cancer diagnosis. Our Artificial Intelligence (AI) software analyses biopsy slides within seconds to find tumour regions and quantify tumour markers to prepare them for visual inspection by the pathologist. In 2018, the number of diagnosed cancer cases has grown to 18 million globally.Consequently, the demand for cancer diagnosis to determine appropriate treatment has never been higher. Cancer diagnosis nowadays is a very time-consuming process and depends heavily on the knowledge and experience of specialised pathologists. Unfortunately, the number of experts can no longer meet the quickly increasing demand. As a result, patients must wait longer than necessary for their diagnosis.To overcome this challenge, MindPeak provides solutions based on deep learning to support pathologists in their diagnosis. Patients benefit from increased accuracy and a faster turn around time of diagnosis as well as reduced costs. The key USP of our AI is its reliability in the clinical context with its variations across and within labs. Funding from the EIC Accelerator will help us with a successful and fast go-to-market of our solutions that cover crucial improvements for cancer patients. With our technology, we address the market for pathology with a current size of $17.3 bn worldwide and an annual growth rate of 6.5%. Champ scientifique natural sciencescomputer and information sciencessoftwaremedical and health sciencesclinical medicineoncologymedical and health sciencesbasic medicinepathologynatural sciencescomputer and information sciencesartificial intelligencemachine learningdeep learning Mots‑clés deep learning machine learning AI cancer pathology biopsy tumour tumor image recognition histology histopathology Programme(s) H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs Main Programme H2020-EU.3. - PRIORITY 'Societal challenges H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies Thème(s) EIC-SMEInst-2018-2020 - SME instrument Appel à propositions H2020-EIC-SMEInst-2018-2020 Voir d’autres projets de cet appel Sous appel H2020-EIC-SMEInst-2018-2020-3 Régime de financement SME-2 - SME instrument phase 2 Coordinateur MINDPEAK GMBH Contribution nette de l'UE € 1 372 378,00 Adresse ZIRKUSWEG 2 20359 Hamburg Allemagne Voir sur la carte PME L’entreprise s’est définie comme une PME (petite et moyenne entreprise) au moment de la signature de la convention de subvention. Oui Région Hamburg Hamburg Hamburg Type d’activité Private for-profit entities (excluding Higher or Secondary Education Establishments) Liens Contacter l’organisation Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Coût total € 1 960 540,00